Prestige Consumer Healthcare (PBH) Free Cash Flow (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Free Cash Flow of $75.3 million for Q4 2025, up 18.47% year-over-year from $63.5 million in Q4 2024, and up 35.89% quarter-over-quarter from $55.4 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Free Cash Flow (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Free Cash Flow history runs 16 years deep, the most recent figure standing at $75.3 million for Q4 2025.
- In Q4 2025, Free Cash Flow rose 18.47% year-over-year to $75.3 million; the TTM figure through Dec 2025 stood at $267.2 million (up 7.44% YoY), while the FY2025 annual figure was $243.3 million, up 1.64% from the prior year.
- Free Cash Flow for Q4 2025 stood at $75.3 million, up from $55.4 million in the prior quarter.
- The five-year high for Free Cash Flow was $78.2 million in Q2 2025, with the low at $46.6 million in Q2 2023.
- The 5-year median for Free Cash Flow is $59.0 million (2021), against an average of $60.9 million.
- The sharpest annual moves came in 2021 and 2023: Free Cash Flow surged 47.29% in 2021, then fell 18.51% in 2023.
- Prestige Consumer Healthcare's Free Cash Flow stood at $64.1 million in 2021, then declined by 17.06% to $53.1 million in 2022, then soared by 30.74% to $69.5 million in 2023, then dropped by 8.57% to $63.5 million in 2024, then rose by 18.47% to $75.3 million in 2025.
- Business Quant data shows PBH's Free Cash Flow at $75.3 million in Q4 2025, $55.4 million in Q3 2025, and $78.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.26 Mn |
| Dec 31, 2025 | 75.26 Mn |
| Sep 30, 2025 | 55.38 Mn |
| Sep 30, 2025 | 55.38 Mn |
| Jun 30, 2025 | 78.18 Mn |
| Jun 30, 2025 | 78.18 Mn |
| Mar 31, 2025 | 58.37 Mn |
| Mar 31, 2025 | 58.37 Mn |
| Dec 31, 2024 | 63.53 Mn |
| Dec 31, 2024 | 63.53 Mn |
| Sep 30, 2024 | 67.77 Mn |
| Sep 30, 2024 | 67.77 Mn |
| Jun 30, 2024 | 53.62 Mn |
| Jun 30, 2024 | 53.62 Mn |
| Mar 31, 2024 | 63.76 Mn |
| Mar 31, 2024 | 63.76 Mn |
| Dec 31, 2023 | 69.48 Mn |
| Dec 31, 2023 | 69.48 Mn |
| Sep 30, 2023 | 59.53 Mn |
| Sep 30, 2023 | 59.53 Mn |